Mohit Manrao, SVP, Head of US Oncology at AstraZeneca, shared a post on LinkedIn:
“This post is intended for a US audience only.
Looking forward to the American Society of Hematology (ASH) Annual Meeting and the chance to connect with the hematology community!
There’s something meaningful about bringing together researchers, clinicians, and industry professionals who are all working toward the same goal – better outcomes for patients with blood cancers and rare diseases.
What we’re sharing this year:
- 65 abstracts from our research teams
- 15 oral presentations across our pipeline
- 8 therapies (both approved and investigational) representing our ongoing work
You can find AstraZeneca and Alexion Pharmaceuticals, Inc. at booth #1343 (and on stage) – this is our largest ASH presence to date.
I hope to connect with you at ASH25 and encourage you to read more about our upcoming presentations.”
More posts featuring Mohit Manrao.